INS and type 1 diabetes mellitus: In this review, we will focus on the potential use of TCR sequences as non-cell based T cell biomarkers for type 1 diabetes (T1D), a tissue-specific autoimmune disease targeting insulin-secreting pancreatic beta cells (1–3).